Summary of Technology Quarterly: Targeting Tumours

Looking for the article?
We have the summary! Get the key insights in just 5 minutes.

Technology Quarterly: Targeting Tumours summary
Start getting smarter:
or see our plans


8 Overall

9 Importance

8 Innovation

8 Style


The Economist’s health care correspondent, Natasha Loder, delves into the status and future of cancer treatment in this incredibly thorough report. She focuses on the science, biotechnology and economics behind treating this deadly disease. While the subject matter is technical and complex, the piece is a fascinating look at one patient’s story, set against the background of extensive research and development of new strategies in the cancer world. getAbstract recommends this article to anyone in biotechnology, as well as physicians, scientists, and those whose lives have been touched by cancer.

In this summary, you will learn

  • What the state of cancer therapy is worldwide,
  • How scientists and clinicians harness the immune system to attack cancer, and
  • What the future of cancer research, development and treatment holds, both medically and financially. 

About the Author

Natasha Loder is the health care correspondent for The Economist. She writes about biotechnology, medical science and the pharmaceutical industry. 



Is there reason for optimism when it comes to cancer?

In some developed countries, nearly half the population will receive a cancer diagnosis in their lifetime. At the same time as the prevalence of cancer increases, more people survive. Innovative research, detection, and therapeutic strategies all give reason for optimism. In fact, treatments based on genetics and immunotherapy – a brand new approach that co-opts the body’s immune system to fight the disease – have had unprecedented success. Despite this good news, the poor, especially people living in the developing world, often lack access to basic treatment. Plus, some simple preventive measures – such as the human papilloma virus vaccine, which prevents cervical cancer – are not even fully in place in the United States.

More on this topic

By the same author

Technology Quarterly: Towards Zero Carbon
Technology Quarterly: Finding a Voice
Once considered a boon to democracy, social media have started to look like its nemesis

Customers who read this summary also read

In a Major Shift, Cancer Drugs Go ‘Tissue-Agnostic’
Death of Cancer
Immune System, Unleashed by Cancer Therapies, Can Attack Organs
The Organoid Architect
Power Couple: Science and Technology
The Greatest Hits of the Human Genome

Related Channels

Comment on this summary